Literature DB >> 10206092

Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

E J Erlandsen1, E Randers, J H Kristensen.   

Abstract

The Dade Behring N Latex Cystatin C assay, a particle-enhanced nephelometric immunoassay for measuring serum cystatin C, was evaluated on the Dade Behring Nephelometer II. The assay time was 6 min and the throughput was 75 samples per hour. The sample volume was 40 microL and the measuring range was 0.25-7.90 mg/L. Imprecision studies revealed within-run CVs < 1.8% and between-run CVs < 1.8% in the concentration range 0.87-4.63 mg/L. Recovery was 92.4-101.3%. Linearity studies showed excellent correlation between the theoretical and obtained values. No interferences were detected from haemoglobin < 1.0 mmol/ L, bilirubin <512 micromol/L and Intralipid <20 g/L. Stability of cystatin C in serum was 7 days at temperatures from 20 degrees C to 20 degrees C and 6 months at -80 degrees C. Measurements of cystatin C in heparin-plasma and EDTA-plasma did not differ significantly from cystatin C measured in serum. Fifty patient samples run on the Dade Behring Nephelometer II (y) were compared to the Dako Cystatin C assay (x). The Passing-Bablok regression analysis revealed y = 1.105x - 0.340. In conclusion, the Dade Behring N Latex Cystatin C assay was precise and correlated with the Dako Cystatin C assay.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206092     DOI: 10.1080/00365519950185940

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  118 in total

1.  Cystatin C and cognitive impairment 10 years later in older women.

Authors:  Yelena Slinin; Katherine W Peters; Areef Ishani; Kristine Yaffe; Howard A Fink; Katie L Stone; Michael Steffes; Kristine E Ensrud
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-01       Impact factor: 6.053

2.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

3.  A prospective study of frailty in nephrology-referred patients with CKD.

Authors:  Baback Roshanravan; Minesh Khatri; Cassianne Robinson-Cohen; Greg Levin; Kushang V Patel; Ian H de Boer; Stephen Seliger; John Ruzinski; Jonathan Himmelfarb; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2012-07-07       Impact factor: 8.860

4.  Obstructive sleep apnea is associated with increased urinary albumin excretion.

Authors:  Michael D Faulx; Amy Storfer-Isser; H Lester Kirchner; Nancy S Jenny; Russell P Tracy; Susan Redline
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

5.  Change in cardiovascular risk factors with progression of kidney disease.

Authors:  Linda F Fried; Ronit Katz; Mary Cushman; Mark Sarnak; Michael G Shlipak; Lewis Kuller; Anne B Newman
Journal:  Am J Nephrol       Date:  2008-10-24       Impact factor: 3.754

6.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

7.  Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Pranav S Garimella; Joachim H Ix; Ronit Katz; Michel B Chonchol; Bryan R Kestenbaum; Ian H de Boer; David S Siscovick; Shani Shastri; Jade S Hiramoto; Michael G Shlipak; Mark J Sarnak
Journal:  Atherosclerosis       Date:  2014-01-04       Impact factor: 5.162

8.  Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study.

Authors:  Tapan Mehta; Petra Bůžková; Mark J Sarnak; Michel Chonchol; Jane A Cauley; Erin Wallace; Howard A Fink; John Robbins; Diana Jalal
Journal:  Metabolism       Date:  2014-11-21       Impact factor: 8.694

9.  The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study.

Authors:  Benjamin D Parker; Leon J Schurgers; Cees Vermeer; Nelson B Schiller; Mary A Whooley; Joachim H Ix
Journal:  Atherosclerosis       Date:  2009-11-22       Impact factor: 5.162

10.  Reduced renal function and sleep-disordered breathing in community-dwelling elderly men.

Authors:  Muna T Canales; Brent C Taylor; Areef Ishani; Reena Mehra; Michael Steffes; Katie L Stone; Susan Redline; Kristine E Ensrud
Journal:  Sleep Med       Date:  2008-08       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.